SCHEMBL20797207

SCHEMBL20797207

CN1CCN(c2cc(-c3ccccc3S(=O)(=O)n3ccc(/C=C/C(=O)Nc4ccccc4N)c3)ccn2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HDAC1 Q13547 17/20 0.55
▸ HDAC2 Q92769 13/20 0.55
▸ HDAC3 O15379 4/20 0.55
▸ HDAC10 Q969S8 4/20 0.55
▸ HDAC11 Q96DB2 4/20 0.55
▸ HDAC9 Q9UKV0 4/20 0.55
▸ KDM1A O60341 1/20 0.55
▸ HDAC4 P56524 3/20 0.43
▸ HDAC7 Q8WUI4 3/20 0.43
▸ HDAC8 Q9BY41 3/20 0.43
▸ HDAC6 Q9UBN7 3/20 0.43
▸ HDAC5 Q9UQL6 3/20 0.43
▸ ABL1 P00519 1/20 0.43
▸ EGFR P00533 1/20 0.43
▸ ERBB2 P04626 1/20 0.43
▸ INSR P06213 1/20 0.43
▸ PDGFRB P09619 1/20 0.43
▸ CDK2 P24941 1/20 0.43
▸ PLK1 P53350 1/20 0.43
▸ RXRA P19793 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3137166 0.89 HDAC1 (0.69) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL3137176 0.89 HDAC1 (0.69) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL3140277 0.88 HDAC1 (0.53) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL3140289 0.88 HDAC1 (0.53) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL27704574 0.80 HDAC1 (0.46) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL3420879 0.80 HDAC1 (0.66) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL3420883 0.80 HDAC1 (0.66) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL3141309 0.79 HDAC1 (0.52) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL3133896 0.78 HDAC1 (0.41) HDAC1HDAC2HDAC3HDAC10HDAC11
SCHEMBL3419142 0.78 HDAC1 (0.53) HDAC1HDAC2HDAC3HDAC10HDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3678740-A1 HDAC INHIBITOR IN COMBINATION WITH IMMUNE CHECKPOINT MODULATOR FOR CANCER THERAPY 4SC AG (DE) 2020-07-15 — — EP disclosed
WO-2019048629-A1 HDAC INHIBITOR IN COMBINATION WITH IMMUNE CHECKPOINT MODULATOR FOR CANCER THERAPY 4SC AG (DE) 2019-03-14 — — WO disclosed
Send feedback